Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04336982
Title A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Celgene

acute myeloid leukemia


Azacitidine + CC-90009 + Venetoclax

CC-90009 + Gilteritinib

Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of California, San Francisco Recruiting San Francisco California 94143-0324 United States Details
Yale New Haven Hospital Not yet recruiting New Haven Connecticut 06510 United States Details
Dana-Farber/Mass General Brigham Cancer Care, Inc Not yet recruiting Boston Massachusetts 02115 United States Details
Washington University School of Medicine Recruiting Saint Louis Missouri 63110 United States Details
Hackensack University Medical Center Recruiting Hackensack New Jersey 07601 United States Details
The University of Texas - MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
Fred Hutchinson Cancer Research Center Not yet recruiting Seattle Washington 98109-1024 United States Details
University of Alberta Recruiting Edmonton Alberta T6G 2R7 Canada Details
Princess Margaret Cancer Centre Not yet recruiting Toronto Ontario M5G 2M9 Canada Details
Hopital Maisonneuve-Rosemont Not yet recruiting Montreal Quebec H1T 2M4 Canada Details
Institut Paoli-Calmettes Recruiting Marseille 13273 France Details
Hopital Haut Leveque Recruiting Pessac Cedex 33604 France Details
Institut Universitaire du Cancer de Toulouse (IUCT) - Oncopole Recruiting Toulouse Cedex 9 31059 France Details
John Radcliffe Hospital Recruiting Oxford OX3 9DU United Kingdom Details
*Shaded cells indicate that there was no data available from for the field